No Data
No Data
No Data
No Data
No Data
Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
EMERYVILLE, Calif., April 24, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, wi
PR NewswireApr 25 04:05
323 drugs, hurry up! America is facing the biggest “drug shortage” in history...
The US now seems to be facing an unprecedented “drug shortage”...
cls.cnApr 15 14:37
Health Check: How Prudently Does Dynavax Technologies (NASDAQ:DVAX) Use Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we thi
Simply Wall StApr 8 18:12
Dynavax Technologies Corp: Appoints Ryan Spencer to Serve as Interim Chief Financial Officer While Kelly MacDonald Is on Maternity Leave
Dynavax Technologies Corp: Appoints Ryan Spencer to Serve as Interim Chief Financial Officer While Kelly MacDonald Is on Maternity Leave
Dow JonesApr 2 04:42
Dynavax (NASDAQ:DVAX) Offers Potentially Robust Growth at a Rich Valuation
TipRanksMar 19 22:09
Chief Accounting Officer Justin Burgess Sells Shares of Dynavax Technologies Corp (DVAX)
Yahoo FinanceMar 5 12:53
No Data
No Data